Rare expression of BSAP (PAX-5) in mature T-cell lymphomas

被引:26
作者
Tzankov, Alexandar S.
Went, Philip T.
Muenst, Simone
Papadopoulos, Thomas
Jundt, Gernot
Dirnhofer, Stephan R.
机构
[1] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Bone Tumor Reference Ctr, CH-4031 Basel, Switzerland
[3] Univ Erlangen Nurnberg, Inst Pathol, D-8520 Erlangen, Germany
关键词
BSAP; PAX-5; peripheral T; cell lymphoma; angioimmunoblastic T;
D O I
10.1038/modpathol.3800778
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Lineage determination in lymphomas is based on the assessment of lineage-specific markers, such as the B-cell-specific activator protein of the paired box family (BSAP, PAX-5) for the B-cell lineage. BSAP is thought to be expressed exclusively in B cells from the pro-B- to the mature B-cell stage and then silenced in plasma cells. BSAP has oncogenic potential and experimental evidence shows that the T-cell lineage is prone to this effect. Herein, we report on a BSAP-positive peripheral T-cell lymphoma with monoclonal T-cell receptor c-gene rearrangement. To assess the relative frequency of BSAP expression in mature T-cell lymphomas, we constructed and examined a tissue microarray consisting of 43 angioimmunoblastic T-cell lymphomas and peripheral T-cell lymphomas and detected no additional BSAP-positive cases. To conclude, BSAP can probably contribute to T-cell lymphomagenesis not only in vitro, but also in vivo. It is rarely expressed in peripheral T-cell lymphoma, thus its detection on lymphoid malignancies cannot be considered definitively lineage specific.
引用
收藏
页码:632 / 637
页数:6
相关论文
共 32 条
  • [1] PAX-5 ENCODES THE TRANSCRIPTION FACTOR BSAP AND IS EXPRESSED IN LYMPHOCYTES-B, THE DEVELOPING CNS, AND ADULT TESTIS
    ADAMS, B
    DORFLER, P
    AGUZZI, A
    KOZMIK, Z
    URBANEK, P
    MAURERFOGY, I
    BUSSLINGER, M
    [J]. GENES & DEVELOPMENT, 1992, 6 (09) : 1589 - 1607
  • [2] Association of Pax5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder
    Babjuk, M
    Soukup, V
    Mares, J
    Dusková, J
    Pecen, L
    Pesl, M
    Pavlík, I
    Dvorácek, J
    [J]. UROLOGY, 2006, 67 (04) : 756 - 761
  • [3] Berthold D, 2004, SWISS MED WKLY, V134, P472
  • [4] Lineaue determination of CD20-B-cell neoplasms: An inummohistochemical study
    Chu, Peiguo G.
    Loera, Sofia
    Huang, Qin
    Weiss, Lawrence M.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 126 (04) : 534 - 544
  • [5] Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas:: Reassessing the reported association with t(9;14)
    Cook, JR
    Aguilera, NI
    Reshmi-Skarja, S
    Huang, X
    Yu, ZS
    Gollin, SM
    Abbondanzo, SL
    Swerdlow, SH
    [J]. HUMAN PATHOLOGY, 2004, 35 (04) : 447 - 454
  • [6] Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells
    Delogu, A
    Schebesta, A
    Sun, Q
    Aschenbrenner, K
    Perlot, T
    Busslinger, M
    [J]. IMMUNITY, 2006, 24 (03) : 269 - 281
  • [7] B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in Merkel cell carcinoma and small cell carcinomas
    Dong, HY
    Liu, W
    Cohen, P
    Mahle, CE
    Zhang, WS
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (05) : 687 - 692
  • [8] T-bet, a T-cell-associated transcription factor, is expressed in a subset of B-cell lymphoproliferative disorders
    Dorfman, DM
    Hwang, ES
    Shahsafaei, A
    Glimcher, LH
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (02) : 292 - 297
  • [9] Iida S, 1996, BLOOD, V88, P1787
  • [10] Jaffe ES., 2001, PATHOLOGY GENETICS T